ABT241220C117000
- 0.03
- -0.01-25.00%
Abbott Laboratories Newsroom
TD Cowen Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $135
RBC Capital Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $135
Piper Sandler Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $133
Abbott Laboratories (ABT) Gets a Buy From Piper Sandler
Bernstein Maintains Abbott Laboratories(ABT.US) With Buy Rating, Cuts Target Price to $133
Goldman Sachs Adjusts Price Target on Abbott Laboratories to $132 From $134, Maintains Buy Rating
Nephron Adjusts Price Target on Abbott Laboratories to $120 From $118
Oppenheimer Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $130
Oppenheimer Sticks to Its Buy Rating for Abbott Laboratories (ABT)
Piper Sandler Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $133
Wells Fargo Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $133
Wells Fargo Sticks to Their Buy Rating for Abbott Laboratories (ABT)
TD Cowen Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $130
Strategic Initiatives and Innovations Drive Buy Rating for Abbott Laboratories
Wells Fargo Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $133
Wells Fargo Reaffirms Their Buy Rating on Abbott Laboratories (ABT)
Wells Fargo Sticks to Its Buy Rating for Abbott Laboratories (ABT)
Abbott Laboratories Analyst Ratings
Barclays Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $149
Barclays Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $149